![Jack Troia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jack Troia
Directeur Financier/CFO chez Omnitura Therapeutics, Inc.
Postes actifs de Jack Troia
Sociétés | Poste | Début | Fin |
---|---|---|---|
Omnitura Therapeutics, Inc.
![]() Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Directeur Financier/CFO | - | - |
Historique de carrière de Jack Troia
Anciens postes connus de Jack Troia
Sociétés | Poste | Début | Fin |
---|---|---|---|
Deloitte & Touche
![]() Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Etats-Unis | 2 |
Taïwan | 2 |
Opérationnelle
Director of Finance/CFO | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Omnitura Therapeutics, Inc.
![]() Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Health Technology |
Deloitte & Touche
![]() Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Commercial Services |
- Bourse
- Insiders
- Jack Troia
- Expérience